ALL STARTUPS
![Background](https://www.hub71.com/storage/media/1004/conversions/pangea-bio-converted-webp.webp?v=1" width="900" height="591" srcset="https://www.hub71.com/storage/media/1004/responsive-images/pangea-bio___converted-webp_900_591.webp 900w, https://www.hub71.com/storage/media/1004/responsive-images/pangea-bio___converted-webp_752_494.webp 752w, https://www.hub71.com/storage/media/1004/responsive-images/pangea-bio___converted-webp_630_414.webp 630w, https://www.hub71.com/storage/media/1004/responsive-images/pangea-bio___converted-webp_527_346.webp 527w)
Pangea Bio
Pangea Bio discovers and develops medication to treat neurological disorders by deploying AI to discover promising molecules from natural sources.
![Logo](https://www.hub71.com/storage/media/1003/conversions/pangea-bio-logo-converted-webp.webp?v=1" width="734" height="294" srcset="https://www.hub71.com/storage/media/1003/responsive-images/pangea-bio-logo___converted-webp_734_294.webp 734w){kind=logo}
-
SECTOR:
Health and Life Sciences
-
FOUNDED IN:
United Kingdom
-
STAGE:
Series A
-
PROGRAM ENROLLED IN:
Access Programme